chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a female patient of an unknown age, referring to a herself. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX injection  (1 single injection subcutaneously) for protection against herpes zoster (strength, lot number and expiration date were not provided). On an unknown date, 6 years post receiving a ZOSTAVAX injection, the patient experienced shingles. As a result of the shingles she was admitted into the hospital for an unspecified amount of time and length. Unspecified treatment was given for the adverse event and no product quality complaint was involved. The outcome of herpes zoster was unknown, as the relatedness with ZOSTAVAX. Additional information is not expected as there was no consent for follow-up.
Arm Red (Injection Site); Itchy arm at injection site; A spontaneous report was received from a consumer, concerning a female patient of unspecified age, who received Moderna's COVID-19 vaccine and experienced Itchy arm at injection site, arm Red.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 29-jan-2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot number 042L20A) via intramuscular route for COVID-19 infection prophylaxis.   On 2-feb-2021  after first dose of vaccine, the patient experienced ongoing red on the injection site and itchy till 17-feb -2021. No treatment medication was reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event, was considered to be unknown at the time of this report.  Based on MSA comment, Vaccination site erythema and Vaccination site pruritus is listed in CCDS also
Redness and inflammation at injection site one week later.  Was told to put. Cold compresses and if gets worse to go to walk in clinic or primary doctors office
day p/vax pt devel nausea, malaise, achy joints, h/a, emotional irritability, diarrhea, fever these lasted throughout vax series; sl lessening toward the end; also devel crohns flare the day p/3rd inj which worsened into bowel obstruction;
Patient developed a fever starting 01/07/2021 and progressed to eventual decrease in condition overall. By 01/09/2021 she was bed bound, NPO, consistent fever, gurgling, hypoxic requiring 2-4 L of oxygen via nasal canula, and significant secretions requiring glycopyrrolate and suction. This progressed for the next days with decreasing condition and increase of above symptoms. Patient eventually could not swallow and developed rhonchi in lungs.
Patient received a 4th dose of Moderna. 1st dose on 1/4/21, 2nd dose on 2/1/21, 3rd dose on 6/17/21, and 4th dose on 8/12/21.
The day after the vaccines were administered the child developed generalize rash in face, chest, back and arms and itchiness. Mother took child to ER where he received IV medication for allergies. The day after treatment all rash was gone and the child completely recuperated.
05 Feb 2021: Patient reports headache, fever, muscle aches and chills starting yesterday evening. Patient states that last night around 2200 became very confused, felt shaky for a brief period, had muscle soreness, sleepiness and confusion for around 30 minutes afterwards. Notes that she had drooled a lot and been incontinent of urine. This morning she continues to have flu like symptoms, appears alert and oriented over the phone.  Patient is going to be escorted to Emergency room for eval.
Donor was given shot. He then became dizzy with blurred vision and sweating. Donor was laid down with legs elevated. Donors vitals taken. 11/17/05 Donor had a cold cloth placed on head. Donor felt better. Given 500 ml of water to drink. Donor watched for 20 min after symptoms went away. Symptoms only lasted 2-3 min.
37 y.o., patient scheduled to receive Pfzier booster dose 1 vaccine on Tuesday, August 2 2022.  When patient presented to vaccination room with Nurse he had 3 prior doses of Pfzier on vaccine record card. Pre-vaccination checklist questions were asked by the nurse prior to administering the vaccine. Due to age and not eligible for a booster #2, the nurse asked his reasoning for wanting to be vaccinated with a fourth dose or if patient presented with a medical condition or immunocompromising conditions. Patient stated was not immune compromised due to medical conditions but wanted to receive the dose due to his intellectual disability and predisposed to covid at a facility he was often visiting. Due to nurse's understanding of CDC guidelines of vaccinators not to deny COVID-19 vaccination to a person due to lack of documentation of immune status and self-report immunocompromised, nurse felt duty bound to administer the vaccine. There was no medical or nurse consult to find the patients eligibility for Booster #2 vs Booster #1.
pt recv vax & lab eval revealed a positive anti-HBc test;pt also tested positive for anti-HBs;
By 9 1/2 area of erythema, swelling, warmth and chaffed skin where DPT was, plus Hx 102F fever X 48 hrs. also developed cold and sore throat 2 days post vaccine.
Very shortly after having the shot, the area swelled up into a circle about two inches in diameter. It became red. Swollen up. Sore. The swelling did not go down for at least a week. I put ice on it.  There is still a slight redness to this area now, almost five weeks after the shot.
Dizziness, Nausea.  Pt reported light HA, VSS, no signs of Resp distress, able to swallow, no other complaints.  Patient stable and released from vaccination site
reported on (name)that he had received his third booster dose.; reported on (name)that he had received his third booster dose.; experienced fatigue, mild headache, and low appetite; experienced fatigue, mild headache, and low appetite; experienced fatigue, mild headache, and low appetite; nausea; dizziness; warm feeling; This is a spontaneous report from contactable Physician via Pfizer Sales Representative. A male patient of an unspecified age received third booster dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 3, single for covid-19 immunisation. Medical history stated patient was immunocompromised due to a prior stem cell transplant on an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date, patient received first dose and second dose of BNT162B2 via an unspecified route of administration for covid-19 immunisation. On an unspecified date, patient stated he had received his third booster dose 12 hours after the dose he experienced fatigue, mild headache, and low appetite, 14 hours after the dose he reported experiencing nausea and dizziness and 17 hours after that he had fatigue, a warm feeling and was nauseated. Patient stated events occurred after use of product. Outcome of al the events were unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected
I had swelling in my eyelids. I could feel my face swelling immediately after I received the vaccine. I could see my eyelids were swollen. I took 2 Benadryl immediately. It took about a day for things to subside. I came home and had cold chills and just felt overall horrible. I went to bed and stayed in bed for 2 days. I called my doctor and had a virtual visit.
reported warm flush on administration of vaccine - then headache & dizziness after driving to 30 min. lot and called for help.  Also reported anxiety / panic with long h/o panic attack - has a service dog who accompanies her.  TX - reclined car seat.  mask removal for air flow.  water & apple juice.  Symptom abated.  Total observation time 40 mins.  Drove off lot independently.
Severe rash on the face and neck. It looks severe skin irritation, redness and inflammation.; Severe rash on the face and neck. It looks severe skin irritation, redness and inflammation.; Severe rash on the face and neck. It looks severe skin irritation, redness and inflammation.; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the second dose of bnt162b2, via an unspecified route of administration, administered in left arm on 13Apr2021 (Lot Number: ER7533) as single dose for covid-19 immunisation. Medical history included Controlled arterial hypertension, NSAIDs allergy. Concomitant medications included Amlodipine, Vitamins C and D, Magnesium. The patient previously received the first dose of bnt162b2, at the age of 65-year-old, via an unspecified route of administration, administered in left arm on 23Mar2021 13:00 (Lot Number: ER 8730) as single dose for covid-19 immunisation. The patient experienced severe rash on the face and neck. It looks severe skin irritation, redness and inflammation. No treatment received. No pregnant at the time of vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
arm is tingling  from fingers to my shoulder; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (arm is tingling  from fingers to my shoulder) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (arm is tingling  from fingers to my shoulder). At the time of the report, PARAESTHESIA (arm is tingling  from fingers to my shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Large, swollen, indurated, erythematous wheel noticed at 7AM on 1/7/2021 Temperature was 99.9 at 11:07AM, 100.4 at 12:38PM, 101.6 at 2:08 PM, 102.3 at 5:30pm on 1/7/2021 During the day, significant muscular pain in the low back and throughout Took Tylenol for first time at 5:45pm with resolution of the fever causing significant sweating.  Abdominal discomfort beginning 1/7/2021 with loose stool 1/8/2021 Fatigue all day 1/7/2020
1. Extreme muscle weakness in legs and arms. Felt very weak on both sides. 2. A lot of difficulty walking had to hold on to walls and doorway to go to bathroom. Very unsteady. 3. Strong chills, body shaking and teeth chattering for over an hour. 4. Extreme pain in back of right knee. Same as a year ago. Could barely bend my left leg. 5. When tried to get back into bed, legs gave out and I fell. a. Not enough strength in legs to roll over or in arms to get up. b. Took a lot of effort to use arms just to sit up but had to lean against bed. 6. Finally had wife call 911. 7. Lost most of Saturday. Would wake for only about 1  2 hours then felt exhausted and went back to sleep.
administered an expired dose of Twinrix on 01/04/2023; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 38-year-old female patient who received HAB (Twinrix) (batch number 4F3YY, expiry date 1st January 2023) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 4th January 2023, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 4th January 2023, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 04-JAN-2023 Reporter's Comments: The medical assistant reported that the patient administered an expired dose of Twinrix. The reporter consented to follow up. Additional Supportive Information: The patient received Twinrix beyond the expiration date, which led to expired vaccine used.
Insomnia then 12 hours after vaccine the headache,dizziness,brain fog. 15 hours after vaccine the shivers come on so strong nothing can get me warm sick to stomach. I literally feel like I am dying.  Have not felt this bad since I was a child.
pt recv vax & exp nausea, cold sweats, joint pain, swollen lymph glands (neck), mild h/a, high BP;no tx given;further info was requested;
Pain and swelling at injection site on the left arm as well as pain in the left axillary lymph nodes which started about 5 hours after the injection. Pain lasted 3 days and the swelling is improving on the third day.  I also experienced 1 day of muscle aches and fatigue on the day after the injection.
I got the Tdap vaccination after my physical on 12/11/2014.  I first got a rash on my chest.  Then, that night my muscles ached badly and I have no appetite.  The next night in conjunction with muscle pain I had camping all night alternating from one calf to the other.  The muscle pain was progressively getting worse during the day so I thought I would go for run hoping to run it out.  Well during the run I experienced vomiting and dizziness, but my legs didn't hurt. After the run the intense muscle pain has returned.  Who knows if the cramps will return tonight? I have gotten a lot of vaccination in my life due to traveling and no other vaccination has cause me even close to this amount of pain.  I really question the medical research concerning this vaccination since this vaccination has only been used since 2006. Is it really necessary to combine all three and since only about 8.2 percent of adults have had this vaccination I reason that the reaction are a lot more adverse than the limited medical research has ascertained.
Ears feel clogged, like the sensation on an airplane (both ears); This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm right on 10Mar2021 at 15:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer in 2012. The patient previously received penicillin and erythromycin and experienced allergy. Concomitant medications included tamoxifen citrate (TAMOXIFEN) and escitalopram (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 20Mar2021, the patient experienced ears feel clogged, like the sensation on an airplane (both ears). The patient did not receive any treatment for the event. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ears feel clogged was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Patient presented in pharmacy on 10/17/2016 with redness, inflammation, and swelling in left arm, more toward the inside and toward elbow, not as much around the injection site.  Went to dermatologist and was given samples of desoximetasone and patient was taking Benadryl.
rash in his groin area; jock-itch; shingles; This case was reported by a consumer via call center representative and described the occurrence of rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th September 2020, the patient received the 1st dose of Shingrix. In September 2020, less than a week after receiving Shingrix, the patient experienced rash, tinea cruris and shingles. On an unknown date, the outcome of the rash was not recovered/not resolved and the outcome of the tinea cruris and shingles were unknown.   It was unknown if the reporter considered the rash, tinea cruris and shingles to be related to Shingrix.  Additional details were as follows: The age at vaccination was not reported.  The patient received 1st dose of Shingrix in left arm. After receiving 1st dose of Shingrix, the patient experienced rash in his groin area, jock itch or shingles. The reporter did not consent to follow up.
1" needle, Left shoulder swelling, redness, pain, 2.3cm x 6cm tender, not firm. Keflex (250mg 15ml) 1 1/2 tsp po 3x 1day x 10 days ice
8/22/08 patient states whole right arm swollen, blotchy, and red. Temp 100.9. Symptoms resolved 8/24/08 except redness which resolved 8/27/08. Used Motrin and ice with relief.
rash on breasts/more on right breast and less on left, bumpy and red; itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (rash on breasts/more on right breast and less on left, bumpy and red) and PRURITUS (itchy) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced RASH ERYTHEMATOUS (rash on breasts/more on right breast and less on left, bumpy and red) and PRURITUS (itchy). The patient was treated with HYDROGEN PEROXIDE at a dose of UNK dosage form and OXYTETRACYCLINE CALCIUM (TERRAMICINA [OXYTETRACYCLINE CALCIUM]) at a dose of UNK dosage form. At the time of the report, RASH ERYTHEMATOUS (rash on breasts/more on right breast and less on left, bumpy and red) and PRURITUS (itchy) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Updated drug and events start date.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (headache). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of 1 dosage form. On 12-Feb-2021, HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: NNI
Immediate tingling down left arm, from injection site to fingertips.  Initially, arm felt a little numb and was aching.  Soreness has continued along with acute pain in shoulder when reaching arm above head (ex., to dress/undress).  A blast of arm pain occurs when any slight "lifting" motion (even lifting the visor in my car, unlatching my purse, picking up a book from a shelf).  Cannot sleep on left side without pain.
Left deltoid hot to touch, very tender, swollen, red.  Swelling & redness measures approximately 3 1/2" X 4" 1:00pm when client came to clinic.  Called and made appointment with Dr. at 1:30pm today for evaluation & treatment if needed.
Body aches, low grade fever, chills, nausea. Treated with Tylenol and home remedies.
Breakthrough case of COVID-19; I felt a really bad sore throat, a lot of coughing and very very tired, and a lot of phlegm.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 51 year old female subject who was vaccinated with Fluarix for prophylaxis. The subject had received influenza virus vaccine in previous years with no subsequent adverse events. On 07 November 2006, the subject received a dose of Fluarix in the right arm. On 07 November 2006, less than one day after vaccination with Fluarix, the subject experienced an injection site reaction described as "a 5.5 by 5.5cm circular pattern, 0.5 inch raised bump that was red, warm and painful." The subject was seen at an emergency room. The outcome of the events was not reported. The healthcare professional considered the events were probably related to vaccination with Fluarix.
March 11 and 12 experienced significant bloody nose events: heavy discharge lasting 20-30 minutes. No previous experience with nose bleeds like the two I experienced yesterday and today.
_severe headache Severe chills Joint pain Muscle aches Nausea Fatigue Feel awful/ weak
Shortness of breath, itching, head congestion, flushed feeling that progressed immediately following injection.  Patient took 75 mg diphenhydramine and symptoms resolved after 2 hours.
10/30/17-by 3pm itching and burning at injection site that progressed to swelling and redness about size of hand. Patient also noted rash and itching on both inner legs from groin down to knee. Patient treated with SARNA lotion. 11/1-patient states fever occurred. 11/2: fever gone; rash and swelling fading/retreating.
Chills, increased temp, and generalized body aches in arms and legs.  Also c/o nausea and knew he would throwup if he ate.
While riding in the car, less than 15 minutes after receiving vaccination, my daughter became very anxious and tearful. For about 10 seconds, she was unable to communicate her distress. Eventually she reported having " sudden tunnel vision and feeling like she was going to pass out and die." Within minutes of the event, she returned to normal and there have been no complications since. Just prior to this episode, she was talking and laughing; perfectly fine. The onset was quite sudden. There was no anxiety related to the procedure either before or after the injection. I discussed with pediatric intensivist. He felt was likely a vagal response requiring no treatment. My daughter is not prone to dramatics, as some teen girls are. The reaction was frightening for her and her family that witnessed.
swelling, redness and itchiness around injection site slight tenderness in lymph node in left arm pit
Started with extreme tiredness around 8 pm same day as vaccine. Woke up with fever and some confusion the next morning. Fever persisted with analgesics on board and hydration efforts for almost 15 hrs.
developed an itchy rash a couple days after the vaccine. It's been flaring up throughout the week
15 minutes after getting the 2nd dose of the vaccine I experienced stiffness in the right side of my neck and ache in my right ear.  this gradually went away and finished out my workday without any additional symptoms. In the early evening about 6pm I was extremely cold and having a difficult time warming up, severe headache, severe body aches, stiffness in my neck.  My ears started ringing and thought it would eventually go away.  All symptoms continued to the next day except for the chills - I was able to get warm.  I was much better by evening and able to go to work the second day after the vaccine but the ringing in my ears never stopped and continues to this day.